Health Care & Life Sciences » Pharmaceuticals | Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc. | Ownership

Companies that own Madrigal Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Capital Research & Management Co. (Global Investors)
1,664,452
10.83%
294,200
0.07%
07/31/2018
Baker Bros. Advisors LP
1,169,278
7.61%
553,594
1.82%
06/30/2018
T. Rowe Price Associates, Inc.
568,128
3.7%
382,109
0.02%
06/30/2018
venBio Select Advisor LLC
489,536
3.19%
489,536
4%
06/30/2018
The Vanguard Group, Inc.
450,427
2.93%
172,794
0%
06/30/2018
BlackRock Fund Advisors
393,403
2.56%
98,125
0.01%
06/30/2018
SSgA Funds Management, Inc.
342,506
2.23%
-117,865
0.01%
06/30/2018
Rock Springs Capital Management LP
342,300
2.23%
16,800
2.98%
06/30/2018
Ecor1 Capital LLC
199,500
1.3%
199,500
4.96%
06/30/2018
HealthCor Management LP
197,281
1.28%
197,281
1.36%
06/30/2018

About Madrigal Pharmaceuticals

View Profile
Address
200 Barr Harbor Drive
West Conshohocken Pennsylvania 19428
United States
Employees -
Website http://www.madrigalpharma.com
Updated 07/08/2019
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.